Mail & Guardian
Mail & Guardian
gonzalez 1latest news & developments
Dolutegravir was initially dubbed a wonder drug but a small possible risk of birth defects stalled a global rollout. South Africa has put strict monitoring in place to catch any potential defects early.
ANTIRETROVIRAL DRUGS

Risks & benefits: new HIV drug combo could change the course of SA’s epidemic

South Africa’s next chapter in HIV treatment holds amazing promise, but unlocking it rests on having the right kind of discussions with women

  • Laura López González
5 min read
The commission’s investigation has produced the largest ever data set on South Africa’s private sector
BHEKISISA CENTRE FOR HEALTH JOURNALISM

Collusion, competition and corruption — A new Rx for better healthcare?

The three Cs: Collusion, competition and corruption. There’ll be a renewed push to safeguard your money when it comes to healthcare, but will it work?

  • Laura López González
4 min read